OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
What is cancer metabolism?
Lydia W.S. Finley
Cell (2023) Vol. 186, Iss. 8, pp. 1670-1688
Open Access | Times Cited: 131
Lydia W.S. Finley
Cell (2023) Vol. 186, Iss. 8, pp. 1670-1688
Open Access | Times Cited: 131
Showing 1-25 of 131 citing articles:
Emerging therapies in cancer metabolism
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 75
Yi Xiao, Tian‐Jian Yu, Ying Xu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1283-1303
Open Access | Times Cited: 75
Metabolic regulation of the hallmarks of stem cell biology
Benjamin T. Jackson, Lydia W.S. Finley
Cell stem cell (2024) Vol. 31, Iss. 2, pp. 161-180
Open Access | Times Cited: 25
Benjamin T. Jackson, Lydia W.S. Finley
Cell stem cell (2024) Vol. 31, Iss. 2, pp. 161-180
Open Access | Times Cited: 25
Molecular and cellular mechanisms underlying the failure of mitochondrial metabolism drugs in cancer clinical trials
Karthik Vasan, Navdeep S. Chandel
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 18
Karthik Vasan, Navdeep S. Chandel
Journal of Clinical Investigation (2024) Vol. 134, Iss. 3
Open Access | Times Cited: 18
NIR-II imaging-guided precise photodynamic therapy for augmenting tumor-starvation therapy by glucose metabolism reprogramming interference
Xiawei Wu, Yong Fan, Kairuo Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 9, pp. 1263-1274
Closed Access | Times Cited: 12
Xiawei Wu, Yong Fan, Kairuo Wang, et al.
Science Bulletin (2024) Vol. 69, Iss. 9, pp. 1263-1274
Closed Access | Times Cited: 12
Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases
Sehyun Oh, Xuan Linh, Jiwoo Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1066-1079
Open Access | Times Cited: 12
Sehyun Oh, Xuan Linh, Jiwoo Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1066-1079
Open Access | Times Cited: 12
The Warburg Effect Explained: Integration of Enhanced Glycolysis with Heterogeneous Mitochondria to Promote Cancer Cell Proliferation
Lilia Alberghina
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15787-15787
Open Access | Times Cited: 26
Lilia Alberghina
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15787-15787
Open Access | Times Cited: 26
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Metabolic remodeling in cancer and senescence and its therapeutic implications
Yeonju Kim, Yeji Jang, Mi-Sung Kim, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 732-744
Closed Access | Times Cited: 8
Yeonju Kim, Yeji Jang, Mi-Sung Kim, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 732-744
Closed Access | Times Cited: 8
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 8
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 8
Glutamine metabolic competition drives immunosuppressive reprogramming of intratumour GPR109A+myeloid cells to promote liver cancer progression
Yang Yang, Tianduo Pei, Chaobao Liu, et al.
Gut (2024), pp. gutjnl-332429
Closed Access | Times Cited: 8
Yang Yang, Tianduo Pei, Chaobao Liu, et al.
Gut (2024), pp. gutjnl-332429
Closed Access | Times Cited: 8
Tumor cell metabolic reprogramming and hypoxic immunosuppression: driving carcinogenesis to metastatic colonization
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Theodora Katopodi, Savvas Petanidis, Doxakis Anestakis, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
ENO1 deletion potentiates ferroptosis and decreases glycolysis in colorectal cancer cells via AKT/STAT3 signaling
Ying Liu, Yinyin Hou, Fan Zhang, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 6
Ying Liu, Yinyin Hou, Fan Zhang, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 6
Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer
Haozhe Zhang, Yi Zhou, Yating Feng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 6
Haozhe Zhang, Yi Zhou, Yating Feng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 6
Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid
Qinghua Wang, Tingting Du, Zhi‐Hui Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4431-4442
Open Access | Times Cited: 6
Qinghua Wang, Tingting Du, Zhi‐Hui Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4431-4442
Open Access | Times Cited: 6
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 6
Hao Wu, Mengdi Fu, Mengwei Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 6
Nanotechnology based gas delivery system: a “green” strategy for cancer diagnosis and treatment
Meixu Chen, Tianyue Xu, Linlin Song, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5461-5491
Open Access | Times Cited: 6
Meixu Chen, Tianyue Xu, Linlin Song, et al.
Theranostics (2024) Vol. 14, Iss. 14, pp. 5461-5491
Open Access | Times Cited: 6
Folate-targeted nanoparticles for glutamine metabolism inhibition enhance anti-tumor immunity and suppress tumor growth in ovarian cancer
Shuning Chen, Yu Jiang, Jiao Zheng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 89-104
Closed Access
Shuning Chen, Yu Jiang, Jiao Zheng, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 89-104
Closed Access
Bioinformatics Analysis and Validation Unveil SLC37A1 as a Novel Biomarker Promoting Cervical Cancer Progression via the Wnt Signaling Pathway
Qing Huang, Yangfeng Xu, Huiping Li, et al.
(2025)
Closed Access
Qing Huang, Yangfeng Xu, Huiping Li, et al.
(2025)
Closed Access
The role of acetylation and deacetylation in cancer metabolism
Cuicui Wang, Xiaoxin Ma
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Cuicui Wang, Xiaoxin Ma
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access
GNA15 induces drug resistance in B cell acute lymphoblastic leukemia by promoting fatty acid oxidation via activation of the AMPK pathway
Jie Luo, Shirui Pan, Jing Luo, et al.
Molecular and Cellular Biochemistry (2025)
Open Access
Jie Luo, Shirui Pan, Jing Luo, et al.
Molecular and Cellular Biochemistry (2025)
Open Access
PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma
Katrina I. Paras, Julia Brunner, Jacob A. Boyer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Katrina I. Paras, Julia Brunner, Jacob A. Boyer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Cytoophidium complexes resonate with cell fates
Yi‐Lan Li, Ji‐Long Liu
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Yi‐Lan Li, Ji‐Long Liu
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Neutrophil extracellular traps in tumor metabolism and microenvironment
Z. Liu, Yuanyao Dou, Conghua Lu, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Z. Liu, Yuanyao Dou, Conghua Lu, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access